New Jersey CyberKnife treats several different types of malignant and benign tumors in the brain, spine, lung, liver,…More pancreas, prostate, kidney and eye using CyberKnife® technology. The CyberKnife is an advanced robotic technology that provides stereotactic radiosurgery and stereotactic body radiation therapy. During these procedures, precisely targeted, high-dose radiation beams are delivered to tumors throughout the body without sedation or incision while radiation exposure to healthy tissue around a tumor is minimized. CyberKnife treatment is painless and is completed in five or fewer procedures. Lung tumors, brain tumors and prostate cancer are frequently treated diseases. New Jersey CyberKnife is part of the J. Phillip Citta Regional Cancer Center and is a service of Community Medical Center, an affiliate of Barnabas Health.
New Jersey CyberKnife at the J. Phillip Citta Regional Cancer Center provides the only CyberKnife program in Ocean County. New Jersey CyberKnife has a dedicated CyberKnife nurse manager who works with our physicians and patients to coordinate care and manage the treatment process. New Jersey CyberKnife has opened two clinical trials in collaboration with the University of Pittsburgh to evaluate stereotactic body radiation therapy for low, intermediate and high-risk prostate cancer patients. Results from these trials will add to the body of clinical research examining stereotactic body radiation therapy for prostate cancer and will help doctors analyze effects and outcomes to improve prostate treatment protocols.